You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,031,007


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,031,007
Title: Pharmaceutical composition with anaesthetic effect
Abstract:The invention is directed to a novel pharmaceutical composition comprising one or more local anaesthetics in oil form, one or more surfactants, water and optionally a taste masking agent. The novel composition is advantageously used as a local anaesthetic for pain relief within the oral cavity.
Inventor(s): Brodin; Arne (Sodertalje, SE), Fynes; Raymond (Mississauga, CA), Heijl; Lars (Lerum, SE), Nyqvist-Mayer; Adela (Tullinge, SE), Scherlund; Marie (Bromma, SE)
Assignee: Astra AB (SE)
Application Number:08/875,888
Patent Claim Types:
see list of patent claims
Composition; Formulation; Use; Process;
Patent landscape, scope, and claims:

United States Patent 6,031,007: A Detailed Analysis of Scope and Claims

Introduction

United States Patent 6,031,007, granted on February 29, 2000, is directed to a new pharmaceutical composition and its use in therapy, particularly as an anesthetic for use on mucous membranes. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Background of the Patent

The patent, titled "Pharmaceutical composition and its use in therapy," describes a novel anesthetic composition designed for topical application, especially on mucous membranes. This invention is significant in the field of pharmaceuticals, particularly in pain management and local anesthesia.

Claims of the Patent

Independent Claims

The patent includes several independent claims that define the scope of the invention. Here are some key claims:

  • Claim 1: This claim describes the pharmaceutical composition comprising a specific anesthetic compound, a solvent, and optionally other additives. It specifies the concentration and the method of preparation[4].

  • Claim 5: This claim focuses on the method of using the pharmaceutical composition for therapeutic purposes, including the application method and the dosage[4].

Dependent Claims

Dependent claims further refine the scope of the independent claims by adding additional limitations or specifications. For example:

  • Claim 2: This claim specifies the type of solvent used in the composition, which is a critical component for the efficacy of the anesthetic[4].

  • Claim 6: This claim details the specific application method, including the duration and frequency of application[4].

Scope of the Invention

The scope of the invention is defined by the claims and the specification. Here are some key aspects:

Pharmaceutical Composition

The patent describes a unique composition that includes an anesthetic compound, a solvent, and optional additives. The composition is designed to be effective as a topical anesthetic, particularly on mucous membranes[4].

Therapeutic Use

The invention is intended for therapeutic use, specifically for providing local anesthesia. The method of use, including application and dosage, is also detailed in the claims[4].

Patent Landscape

Related Patents

The patent landscape in the field of pharmaceutical compositions and local anesthetics is complex. Other patents may cover similar or related inventions, such as different anesthetic compounds or methods of application.

  • Continuations and Continuations-in-Part: Similar to other patents, this patent could be part of a family of patents, including continuations or continuations-in-part, which extend the scope of the original invention[1].

Regulatory Considerations

Patents in the pharmaceutical sector are subject to various regulatory considerations, including those related to the approval of new drugs and the extension of patent terms due to regulatory delays.

  • Patent Term Adjustment (PTA): Patents may be eligible for PTA if there are delays during the prosecution process. However, this adjustment does not extend the patent term beyond the date of a terminal disclaimer[1].

Claim Construction and Indefiniteness

Claim construction is crucial in defining the scope of a patent. The claims must be clear and definite to inform those skilled in the art about the scope of the invention.

  • Legal Standards: The Federal Circuit has established that claim indefiniteness is a legal conclusion that requires the claims to be precise enough to afford clear notice of what is claimed. The claims must be viewed in the context of the specification and the prosecution history[2].

Economic and Practical Implications

Market Impact

The invention described in this patent could have significant market impact, particularly in the field of pain management and local anesthesia. The unique composition and method of application could offer advantages over existing products.

Litigation and Enforcement

Given the potential market impact, this patent could be subject to litigation. The clarity and definiteness of the claims are critical in defending the patent against infringement claims or challenges to its validity.

Data and Statistics

The USPTO provides datasets that can be used to analyze patent claims and scope. For example, the Patent Claims Research Dataset contains detailed information on claims from U.S. patents granted between 1976 and 2014, which can be used to understand trends and patterns in patent claims[3].

Small Claims Patent Court Considerations

In the context of potential disputes or enforcement, the concept of a small claims patent court is relevant. Such a court could provide a more streamlined and cost-effective way to resolve patent disputes, which is particularly important for smaller entities or individual inventors[5].

Expert Insights

Industry experts and legal practitioners often provide valuable insights into the patent landscape. For instance, experts involved in the study on small claims patent courts highlight the need for clear and enforceable patent claims to ensure that inventors can protect their inventions effectively[5].

Key Takeaways

  • Clear Claims: The claims of the patent must be clear and definite to define the scope of the invention.
  • Regulatory Considerations: Patents in the pharmaceutical sector are subject to regulatory considerations, including PTA and terminal disclaimers.
  • Market Impact: The invention has the potential for significant market impact in pain management and local anesthesia.
  • Litigation: Clear and definite claims are crucial in defending the patent against litigation.
  • Data Analysis: Datasets from the USPTO can provide insights into patent claims and scope.

FAQs

What is the main subject of United States Patent 6,031,007?

The main subject of this patent is a new pharmaceutical composition and its use as an anesthetic for mucous membranes.

How are the claims of this patent constructed?

The claims are constructed to define the pharmaceutical composition, its components, and the method of therapeutic use. They include both independent and dependent claims.

What is the significance of Patent Term Adjustment (PTA) in this context?

PTA is significant as it adjusts the patent term due to delays during the prosecution process, but it does not extend the term beyond the date of a terminal disclaimer.

How does the patent landscape affect this invention?

The patent landscape includes related patents and regulatory considerations that can impact the scope and enforcement of this patent.

Why is claim construction important for this patent?

Claim construction is important because it must be clear and definite to inform those skilled in the art about the scope of the invention, which is crucial for defending the patent against challenges.

Cited Sources

  1. In re Cellect, LLC, United States Court of Appeals for the Federal Circuit, August 28, 2023.
  2. Nature Simulation Systems Inc. v. Autodesk, Inc., United States Court of Appeals for the Federal Circuit, October 17, 2022.
  3. Patent Claims Research Dataset, United States Patent and Trademark Office, August 28, 2017.
  4. United States Patent 6,031,007, February 29, 2000.
  5. U.S. Patent Small Claims Court, Administrative Conference of the United States, 2022.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,031,007

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,031,007

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden9601421Apr 12, 1996
PCT Information
PCT FiledApril 01, 1997PCT Application Number:PCT/SE97/00566
PCT Publication Date:October 23, 1997PCT Publication Number: WO97/38675

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.